Vantage Point: Pharmas should become diversified healthcare companies

For several years now, people have been writing off the pharmaceutical industry. Blockbuster drugs losing their patents, in concert with decreasing numbers of drug approvals, have caused Wall Street to devalue this sector. The “generic cliff” coming up in the next few years has deepened this dismay. I repeatedly have written that pharmas should de-focus on drugs and focus on becoming diversified healthcare companies.

But just yesterday, I received an article from my son, a financial analyst, that perhaps paints a different picture. In the second quarter of 2009, the article reported, the FDA approved 13 new molecules, twice the average of six in the previous four quarters. A Morgan Stanley analyst believes that a March US Supreme Court ruling that drugmakers can still be held liable for a drug even if FDA approved has made the agency less risk averse.
Moreover, the roster of new drugs includes potentially important agents for the management of schizophrenia and diabetes. Traditional pharmas and biotechs are forming new and potentially significant partnerships to make these drugs successful. 

Because the industry that will emerge in rebirth will not be identical to the one we have historically known and loved, it also means that we had best begin immediately to adapt new methodologies and data sets to dealing with the opportunities and challenges presented by this new age.

People will keep getting sick, new and better medicines will continue to be developed to deal with illnesses and reasons are emerging to believe that, with appropriate modifications for marketing research procedures in the future, we can look forward to an exciting and profitable new era in the pharma sector.

Richard Vanderveer is CEO of GfK Healthcare

You must be a registered member of MMM to post a comment.

Email Newsletters


As US pharma continued its quest for a Grand Prix at the Lions Health international festival of creativity, MM&M went on location to Cannes, France. Missed our coverage from June? Now, we're giving you an opportunity to catch up on some of what you missed. Download our e-book on the two-day festival, recapping the event, rounding up the best of the speakers, offering perspective and listing all of the winners. Click here to download.


The most recent MM&M Skill Sets Live event surveyed a range of issues relating to one of the hottest promotional spaces in healthcare. Speakers and panelists at the morning-long session, including promotional- and multichannel-minded executives from GSK, Epocrates, Treato and Montefiore Medical Center, weighed in on topics designed to help marketers demystify the challenges associated with non-personal promotion. Click here.